0
Beta-blockers:
destressing the septic patient
UNSW
John Myburgh
MBBCh PhD FCICM FAICD
The George Institute for Global Heal...
Arthur Guyton
1919-2003
Cardiac function
Right atrial pressure (mmHg)
0
10
Venous return
l/min
Cardiac function
Mean systemic pressure
Guyton: 1953
Cardiac failure
Right atrial pressure (mmHg)
0
10
Cardiac failure
Normal
Normal
l/min
Guyton: 1953
Cardiac failure
Right atrial pressure (mmHg)
0
10
Cardiac failure
Francis : Am Heart J 1982
l/min
Venoconstriction
Cardiac failure
Right atrial pressure (mmHg)
0
10
Catecholamines Catecholamines
l/min
Francis : Am Heart J 1982
Septic shock
Right atrial pressure (mmHg)
0
10
Normal
Normal
Jacobsohn: Can J Anes 1997
l/min
Septic shock
Right atrial pressure (mmHg)
0
10 Vasoplegia
l/min
Vasoplegia
Jacobsohn: Can J Anes 1997
Septic shock
Right atrial pressure (mmHg)
0
10
Cardiac
depression
l/min
Jacobsohn: Can J Anes 1997
Septic shock
Right atrial pressure (mmHg)
0
10
l/min
Fluid / catecholamines
Catecholamines
Jacobsohn: Can J Anes 1997
Hein: Cell Tissue Research 2006
Neurohormonal vasoregulation
Neurohormonal vasoregulation
Sadowska : J Physiol Pharm 2006
VP
Noradrenaline
Adrenaline
Cortisol
Cardiac failure
Spectrum of pathology
Compensated Decompensated
Acute
Chronic
Spectrum of treatment
Compensated Decompensated
Neurohormonal
modulation
Acute
Chronic
Pharmacological
augmentation
Cardia...
Spectrum of treatment
Compensated Decompensated
Acute
Chronic
ACE inhibitors
AT-II inhibitors
βBlockade
Catecholamines
Diu...
Cardiac failure and β-blockade
Abraham: Arch Int Med 2001
Carvedilol: NYHA II-III
Bisoprolol: NYHA III-IV
β-blockade and outcomes in CHF
Shibata: Eur J Heart Failure 2001
Mortality and hospital admission
Pooled effect: 0.68, P<0...
ACS / PCI and β-blockade
ACS / PCI and β-blockade
Whole cohort: (n=3 692) Low LVEF: (n=450)
Bao: Cardiovasc Interv Ther 2013
Database registry 2005...
Angus: NEJM 2013
β-blockade and sepsis
Ackland: Crit Care Med 2010
Hepatic
Myocardial
48h pre-LPS
6h post-LPS
Previous β-blockade and sepsis
Macchia: Crit Care Med 2012
Database linkage: 2003-2008
1061/ 8404 patients with sepsis
28-...
Rivers: NEJM 2001
MAP targets
MAP targets
Myburgh: ICM 2008
MAP targets
Asfar:NEJM 2014
Multicentre, pragmatic, POC, RCT
Catecholamine-dependent sepsis
65-70 vs 80-85mmHg x 5 days
MAP targets
Asfar:NEJM 2014
p=0.57 p=0.74
Multicentre, pragmatic, POC, RCT
Catecholamine-dependent sepsis
65-70 vs 80-85mm...
Lactate targets
James: Lancet 1999 Myburgh: ICM 2008
Heart rate target
Phase II, single centre, open-label prospective RCT
Β-blocker naïve
Catecholamine dependent sepsis : MAP>65, CI > 2.2 l/m/...
The quest for meaningful outcomes
NICE-SUGAR: NEJM 2009 DECRA: NEJM 2011
Conclusions
Neurohormonal regulation is a complex biological process.
Neurohormonal modulation is a complex therapeutic in...
Conclusions
The efficacy of β-blockade in chronic heart failure has been
determined in large RCTs.
The efficacy of β-block...
Conclusions
Caution is required with neuroendocrine intervention in
critically ill patients.
A pragmatic RCT to test the e...
John F Kennedy
1917-1963
“Too often we enjoy the
comfort of opinion
without the discomfort of
thought”
Myburgh, John — Beta blockers and De-stressing the Septic Patient
Upcoming SlideShare
Loading in...5
×

Myburgh, John — Beta blockers and De-stressing the Septic Patient

2,129

Published on

John Myburgh on the emerging evidence for the use of beta-blockade in sepsis. Direction for future research.

Published in: Health & Medicine
0 Comments
2 Likes
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total Views
2,129
On Slideshare
0
From Embeds
0
Number of Embeds
5
Actions
Shares
0
Downloads
31
Comments
0
Likes
2
Embeds 0
No embeds

No notes for slide

Transcript of "Myburgh, John — Beta blockers and De-stressing the Septic Patient"

  1. 1. Beta-blockers: destressing the septic patient UNSW John Myburgh MBBCh PhD FCICM FAICD The George Institute for Global Health St George Clinical School, University of New South Wales
  2. 2. Arthur Guyton 1919-2003
  3. 3. Cardiac function Right atrial pressure (mmHg) 0 10 Venous return l/min Cardiac function Mean systemic pressure Guyton: 1953
  4. 4. Cardiac failure Right atrial pressure (mmHg) 0 10 Cardiac failure Normal Normal l/min Guyton: 1953
  5. 5. Cardiac failure Right atrial pressure (mmHg) 0 10 Cardiac failure Francis : Am Heart J 1982 l/min Venoconstriction
  6. 6. Cardiac failure Right atrial pressure (mmHg) 0 10 Catecholamines Catecholamines l/min Francis : Am Heart J 1982
  7. 7. Septic shock Right atrial pressure (mmHg) 0 10 Normal Normal Jacobsohn: Can J Anes 1997 l/min
  8. 8. Septic shock Right atrial pressure (mmHg) 0 10 Vasoplegia l/min Vasoplegia Jacobsohn: Can J Anes 1997
  9. 9. Septic shock Right atrial pressure (mmHg) 0 10 Cardiac depression l/min Jacobsohn: Can J Anes 1997
  10. 10. Septic shock Right atrial pressure (mmHg) 0 10 l/min Fluid / catecholamines Catecholamines Jacobsohn: Can J Anes 1997
  11. 11. Hein: Cell Tissue Research 2006 Neurohormonal vasoregulation
  12. 12. Neurohormonal vasoregulation Sadowska : J Physiol Pharm 2006 VP Noradrenaline Adrenaline Cortisol
  13. 13. Cardiac failure Spectrum of pathology Compensated Decompensated Acute Chronic
  14. 14. Spectrum of treatment Compensated Decompensated Neurohormonal modulation Acute Chronic Pharmacological augmentation Cardiac failure
  15. 15. Spectrum of treatment Compensated Decompensated Acute Chronic ACE inhibitors AT-II inhibitors βBlockade Catecholamines Diuretics Cardiac failure
  16. 16. Cardiac failure and β-blockade Abraham: Arch Int Med 2001 Carvedilol: NYHA II-III Bisoprolol: NYHA III-IV
  17. 17. β-blockade and outcomes in CHF Shibata: Eur J Heart Failure 2001 Mortality and hospital admission Pooled effect: 0.68, P<0.00001
  18. 18. ACS / PCI and β-blockade
  19. 19. ACS / PCI and β-blockade Whole cohort: (n=3 692) Low LVEF: (n=450) Bao: Cardiovasc Interv Ther 2013 Database registry 2005-2007 PCI within 24h STEMI Β-blockade at hospital dischage
  20. 20. Angus: NEJM 2013
  21. 21. β-blockade and sepsis Ackland: Crit Care Med 2010 Hepatic Myocardial 48h pre-LPS 6h post-LPS
  22. 22. Previous β-blockade and sepsis Macchia: Crit Care Med 2012 Database linkage: 2003-2008 1061/ 8404 patients with sepsis 28-day mortality: β-blocker: 188/1061 (17.7%) No β-blocker: 1857/ 8404 (22.1%) OR 0.78 (0.66 to 0.93)
  23. 23. Rivers: NEJM 2001 MAP targets
  24. 24. MAP targets Myburgh: ICM 2008
  25. 25. MAP targets Asfar:NEJM 2014 Multicentre, pragmatic, POC, RCT Catecholamine-dependent sepsis 65-70 vs 80-85mmHg x 5 days
  26. 26. MAP targets Asfar:NEJM 2014 p=0.57 p=0.74 Multicentre, pragmatic, POC, RCT Catecholamine-dependent sepsis 65-70 vs 80-85mmHg x 5 days
  27. 27. Lactate targets James: Lancet 1999 Myburgh: ICM 2008
  28. 28. Heart rate target
  29. 29. Phase II, single centre, open-label prospective RCT Β-blocker naïve Catecholamine dependent sepsis : MAP>65, CI > 2.2 l/m/m2 Esmolol 25mg/hr + 50 mg/h to HR 80-94 Morelli: JAMA 2013
  30. 30. The quest for meaningful outcomes NICE-SUGAR: NEJM 2009 DECRA: NEJM 2011
  31. 31. Conclusions Neurohormonal regulation is a complex biological process. Neurohormonal modulation is a complex therapeutic intervention β-blockade is a small component of modulatory therapy
  32. 32. Conclusions The efficacy of β-blockade in chronic heart failure has been determined in large RCTs. The efficacy of β-blockade after ACS remains uncertain The biological effects of β-blockade in inflammatory states are complex, but tantalising based on animal and observational studies
  33. 33. Conclusions Caution is required with neuroendocrine intervention in critically ill patients. A pragmatic RCT to test the effects of β-blockade on patient- centred outcomes in sepsis is required.
  34. 34. John F Kennedy 1917-1963 “Too often we enjoy the comfort of opinion without the discomfort of thought”
  1. A particular slide catching your eye?

    Clipping is a handy way to collect important slides you want to go back to later.

×